Furthermore, TILs inherently express chemokine receptors (e.g., CCR5, CXCR3), facilitating homing to tumor sites and enhanced infiltration into the tumor microenvironment (TME) post-reinfusion, which amplifies their localized cytotoxic efficacy (135). The gene discussed is CCR5; the disease is neoplasm.